Ontology highlight
ABSTRACT:
SUBMITTER: Sampat BN
PROVIDER: S-EPMC5880378 | biostudies-other | 2018
REPOSITORIES: biostudies-other
PloS one 20180402 4
India, like many developing countries, only recently began to grant pharmaceutical product patents. Indian patent law includes a provision, Section 3(d), which tries to limit grant of "secondary" pharmaceutical patents, i.e. patents on new forms of existing molecules and drugs. Previous research suggests the provision was rarely used against secondary applications in the years immediately following its enactment, and where it was, was redundant to other aspects of the patent law, raising concern ...[more]